CN104758619A - Medicine for treating postpartum hemorrhage - Google Patents

Medicine for treating postpartum hemorrhage Download PDF

Info

Publication number
CN104758619A
CN104758619A CN201510185804.8A CN201510185804A CN104758619A CN 104758619 A CN104758619 A CN 104758619A CN 201510185804 A CN201510185804 A CN 201510185804A CN 104758619 A CN104758619 A CN 104758619A
Authority
CN
China
Prior art keywords
parts
herba
postpartum hemorrhage
medicine
medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510185804.8A
Other languages
Chinese (zh)
Inventor
任红霞
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201510185804.8A priority Critical patent/CN104758619A/en
Publication of CN104758619A publication Critical patent/CN104758619A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a medicine for treating postpartum hemorrhage. The medicine is prepared from the following substances in parts by weight: 80 parts of cynantum amplexicaule ver.castunlum, 70 parts of polypodium vulgare, 60 parts of leucosceptrum canum, 65 parts of sonchus brachyotus, 60 parts of twigs and leaves of taperleaf Japanese spiraea, 50 parts of bredia amoena, 55 parts of abrus cantoniensis hance, 50 parts of cymbidium hookerianum, 45 parts of myriaceis nepalensis less and 30 parts of Japanese glorybower flower. The medicine is available in raw materials and accurate in curative effect; and an experiment proves that the effective rate is high and the cost is low.

Description

A kind of medicament for the treatment of postpartum hemorrhage
Technical field
The present invention relates to field of medicaments, relate in particular to a kind of medicament for the treatment of postpartum hemorrhage.
Background technology
Postpartum hemorrhage refers to bleeding profusely of being difficult to puerperal to stop.This is that one is very serious, but not too common complication.If process in time would not critical life.Uterus is too lax or fail to tighten due to long-term beaten childbirth, produces wound and crosses and mostly likely bleed.Metreurysma excessive may, polyhydramnios, puerpera physical weakness individual large due to multiple birth, fetus as anemia, frightened, or overtired caused by.Placenta Hominis deformity, also can stop uterus symmetric shrinkage.Prevention and corntrol is carried out in clinical generally employing oxytocin at present, though effect is better, due to the necessary drug administration by injection of oxytocin, and individual sensitivity differs greatly, and therefore there is inconvenience when actual therapeutic is applied.
Summary of the invention
The object of this invention is to provide a kind of medicament for the treatment of postpartum hemorrhage.
In order to realize object of the present invention, the invention provides a kind of medicament for the treatment of postpartum hemorrhage, it is made up of the material of following weight parts: pale reddish brown Radix Cynanchi Amplexicaulis 80 parts, adder's-fern 70 parts, meter Tuan Hua 60 parts, Herba Sonchi Arvensis 65 parts, Ramulus Et folium Spiraeae Acuminatae 60 parts, Herba Brediae Amoenae 50 parts, Herba Abri 55 parts, Cymbidium hookerianum 50 parts, oil head grass 45 parts and Flos clerodendri japonici 30 parts.
Preferably, described medicament can make tablet, dispersible tablet, capsule or powder.
The present invention also provides the purposes of compositions in the medicament of preparation treatment postpartum hemorrhage, and described medicament is made up of the material of following weight parts: pale reddish brown Radix Cynanchi Amplexicaulis 80 parts, adder's-fern 70 parts, meter Tuan Hua 60 parts, Herba Sonchi Arvensis 65 parts, Ramulus Et folium Spiraeae Acuminatae 60 parts, Herba Brediae Amoenae 50 parts, Herba Abri 55 parts, Cymbidium hookerianum 50 parts, oil head grass 45 parts and Flos clerodendri japonici 30 parts.
In the present compositions, pale reddish brown Radix Cynanchi Amplexicaulis, adder's-fern are monarch drug, and meter Tuan Hua, Herba Sonchi Arvensis, Ramulus Et folium Spiraeae Acuminatae, Herba Brediae Amoenae are ministerial drug, and Herba Abri, Cymbidium hookerianum, oil head grass are adjuvant drug, and Flos clerodendri japonici is for making medicine.
Pale reddish brown Radix Cynanchi Amplexicaulis
Former plant Cynanchum amplexicaule (Sieb.et Zucc.) Hemsl.var.castaneum Makino
Adder's-fern
Former plant Polypodium vulgare L.
Raw material of the present invention is easy to get, determined curative effect, and prove that effective percentage is high through test, cost is low.
Detailed description of the invention
Below by way of the description of detailed description of the invention, the invention will be further described, but this is not limitation of the present invention, those skilled in the art are according to basic thought of the present invention, various amendment or improvement can be made, but only otherwise depart from basic thought of the present invention, all within the scope of the present invention.
The preparation of embodiment powder of the present invention
Get pale reddish brown Radix Cynanchi Amplexicaulis 80 grams, adder's-fern 70 grams, meter Tuan Hua 60 grams, Herba Sonchi Arvensis 65 grams, Ramulus Et folium Spiraeae Acuminatae 60 grams, Herba Brediae Amoenae 50 grams, Herba Abri 55 grams, Cymbidium hookerianum 50 grams, oil head grass 45 grams and Flos clerodendri japonici 30 grams, pulverize, cross 100 mesh sieves, then sucrose 550 grams is added, mixing, in loading 100 bags and get final product.
Experimental example
Diagnostic criteria:
The diagnostic criteria of postpartum hemorrhage: after delivery of baby in 24 hours blood loss more than 500 milliliters.
The measuring method of postpartum hemorrhage: all cases adopts volumetric method and weight method.Vaginal delivery: work as delivery of baby, amniotic fluid flows to end, and is encased inside at once to connect blood device with milliliter scale under puerpera's buttocks, then pours the blood connect in blood device into measuring cup accurate-metering; Weight method is puerpera's dressing used before childbirth, disinfecting towel is all weighed, and the dressing soaked by blood puerperal, disinfecting towel, disposable waterproof sterilizing paper washer are weighed, and deduct just weight, are equivalent to the criterion calculation blood loss of 1ml blood by proportion 1.05g.Cesarean section delivery: after cutting maternal uterine wall, first exhausted by amniotic fluid, then to connect blood device collection blood, the computational methods of amount of bleeding is same as vaginal delivery.
Choose patient 80 example meeting above-mentioned diagnostic criteria, minimum 26 years old of age, maximum 35 years old, 29.5 years old mean age.
Use powder obtained in embodiment to treat, wherein one day 2 times, oral one bag at every turn 5 days is 1 course for the treatment of.Treatments period is stopped using other medicaments.
Criterion of therapeutical effect
Situation is improved as curative effect judging standard using the every symptom of hemorrhagic disease:
Cure: clinical symptoms and sign are all eliminated, lab testing urine pregnancy tests is negative, and ultrasound diagnosis belongs to normal uterus adnexa ultrasonogram, and efficacy consolidation;
Effective: clinical symptoms and sign make moderate progress;
Invalid: clinical symptoms, sign are not improved.
Result
Through treatment, find that all patient clinical symptoms and sign are all eliminated, lab testing urine pregnancy tests is negative, and ultrasound diagnosis belongs to normal uterus adnexa ultrasonogram, therefore all meets the criterion of therapeutical effect of healing.And do not find obvious untoward reaction over the course for the treatment of.

Claims (3)

1. treat the medicament of postpartum hemorrhage for one kind, it is characterized in that, it is made up of the material of following weight parts: pale reddish brown Radix Cynanchi Amplexicaulis 80 parts, adder's-fern 70 parts, meter Tuan Hua 60 parts, Herba Sonchi Arvensis 65 parts, Ramulus Et folium Spiraeae Acuminatae 60 parts, Herba Brediae Amoenae 50 parts, Herba Abri 55 parts, Cymbidium hookerianum 50 parts, oil head grass 45 parts and Flos clerodendri japonici 30 parts.
2. the medicament for the treatment of postpartum hemorrhage according to claim 1, is characterized in that, described medicament can make tablet, dispersible tablet, capsule or powder.
3. the purposes of compositions in the medicament of preparation treatment postpartum hemorrhage, it is characterized in that, described medicament is made up of the material of following weight parts: pale reddish brown Radix Cynanchi Amplexicaulis 80 parts, adder's-fern 70 parts, meter Tuan Hua 60 parts, Herba Sonchi Arvensis 65 parts, Ramulus Et folium Spiraeae Acuminatae 60 parts, Herba Brediae Amoenae 50 parts, Herba Abri 55 parts, Cymbidium hookerianum 50 parts, oil head grass 45 parts and Flos clerodendri japonici 30 parts.
CN201510185804.8A 2015-04-20 2015-04-20 Medicine for treating postpartum hemorrhage Pending CN104758619A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510185804.8A CN104758619A (en) 2015-04-20 2015-04-20 Medicine for treating postpartum hemorrhage

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510185804.8A CN104758619A (en) 2015-04-20 2015-04-20 Medicine for treating postpartum hemorrhage

Publications (1)

Publication Number Publication Date
CN104758619A true CN104758619A (en) 2015-07-08

Family

ID=53640939

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510185804.8A Pending CN104758619A (en) 2015-04-20 2015-04-20 Medicine for treating postpartum hemorrhage

Country Status (1)

Country Link
CN (1) CN104758619A (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103223155A (en) * 2013-05-20 2013-07-31 刘奎泉 Medicament for treating postpartum hemorrhage

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103223155A (en) * 2013-05-20 2013-07-31 刘奎泉 Medicament for treating postpartum hemorrhage

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
南京中医药大学: "《中药大辞典》", 31 March 2006, article "合掌消、多足蕨、米团花、苣荬菜、吹火筒、秀丽野海棠、虎头兰、油头草、荷苞花" *
蒋雷等: "苣荬菜化学成分的研究", 《食品与药品》, vol. 11, no. 03, 10 March 2009 (2009-03-10), pages 27 *
谢爱玲: "产后出血的干预性治疗概况", 《广西中医学院学报》, vol. 6, no. 04, 30 December 2003 (2003-12-30), pages 69 *

Similar Documents

Publication Publication Date Title
CN103223155B (en) Medicament for treating postpartum hemorrhage
CN104623502A (en) Traditional Chinese medicine composition for calming fetus
CN102764322B (en) Traditional Chinese medicine composite for curing sterility and irregular menstruation
CN103349766B (en) Pharmaceutical composition for endless postpartum lochia
CN112426502B (en) Application of young chicken essence in preparation of thin endometrium treatment drug
CN102078565B (en) Traditional Chinese medicine prescription for treating ectopic pregnancy
CN104758619A (en) Medicine for treating postpartum hemorrhage
CN105943758B (en) A kind of Chinese medicine composition that treating infertility and its application
CN101773627B (en) Chinese medicament for treating postpartum lochiorrhea
CN108498705A (en) Vagina doubts glue bolt and preparation method thereof
CN104800478A (en) Traditional Chinese medicine for treating sterility of ovulation disturbance
CN104524315A (en) Pharmaceutical composition for treating threatened abortion
CN108607043A (en) A kind of medicament for treating postpartum haemorrhage
CN103550525B (en) Drug for treating pubertal dysfunctional uterine bleeding
CN103520487B (en) A kind of purposes of pharmaceutical composition
CN103330887B (en) Pharmaceutical composition for treatment of postpartum lochiorrhea
CN103550372B (en) Medicament for medical abortion
CN107007652A (en) Purposes of the Kangfuxin Liquid Combined with Chinese Herbal in the medicine for preparing treatment infertility
CN103989737A (en) Preparation method for pharmaceutical composition for treating chronic pelvic inflammation
CN105232971A (en) Traditional Chinese medicine composition for treating metrorrhagia and metrostaxis with kidney yin deficiency symptom
CN101797362B (en) Traditional Chinese medicine composite and preparation method thereof for treating uterine myoma of qi stagnation and blood stasis type
CN103263556B (en) A kind of purposes of herbal mixture
Wang et al. Analysis of uterine artery and sex hormones in treating diminished ovarian reserve with tiaojing decoction
CN104758626B (en) A kind of medicament for drug induced abortion
CN101559147A (en) Prescription of novel pure traditional Chinese medicine preparation for curing hysteromyoma

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
EXSB Decision made by sipo to initiate substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20150708